Epinephrine-induced Insulin Resistance in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Items 301–400 of 556
Hjøllund, E., Pedersen, O. B., Richelsen, B., Beck‐Nielsen, H., & Sørensen, N. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112213 · Cited by 17
Fasting Glucose Is a Risk Factor For Breast Cancer
Muti, P. C., Quattrin, T., Grant, B. J. B., et al. (2002) · Cancer Epidemiology and Prevention Biomarkers · Cited by 18
The Insulin Receptor Tyrosine Kinase
Rothenberg, P., White, M. F., & Kahn, C. R. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74098-5_11 · Cited by 20
Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism
Chambrier, C., Picard, S., Vidal, H., Cohen, R., Riou, J. P., & Beylot, M. (1990) · Metabolism · doi:10.1016/0026-0495(90)90311-y · Cited by 20
Pretty, C. G. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2015 · Cited by 23
Richter, E. A. (1996) · Comprehensive Physiology · doi:10.1002/cphy.cp120120 · Cited by 18
Roche, J., Corgosinho, F. C., Dâmaso, A. R., Isacco, L., Miguet, M., Fillon, A., Guyon, A., Moreira, G. A., Pradella-Hallinan, M. L. D. C., Tufik, S., et al. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.003 · Cited by 21
Guo, Q., Minami, N., Nobuyoshi, M. O. R. I., Nagasaka, M., Ito, O., Kurosawa, H., Kanazawa, M., & Kohzuki, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.525 · Cited by 17
“Second, sympathetic activation impairs tissue IS, acting primarily through β-adrenergic receptors (23) or α1-adrenergic receptors on adipocytes (24).”
BackgroundGiugliano, D., Acampora, R., Marfella, R., Marca, C. L., Marfella, M., Nappo, F., & D'Onofrio, F. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00319-1 · Cited by 18
Insulin‐antagonistic effects of counterregulatory hormones: Clinical and mechanistic aspects
Smith, U., & Lager, I. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050604 · Cited by 19
Shamoon, H., & Sherwin, R. S. (1984) · Diabetologia · doi:10.1007/bf00252404 · Cited by 16
“inantly, if not entirely, by fl-adrenergic mechanisms [5, 6].”
BackgroundEffect of beta-adrenergic blockade on weight changes in patients with chronic heart failure
Sze, S., Pellicori, P., Kamzi, S., Anton, A., & Clark, A. L. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.089 · Cited by 16
Cheng, E. T. W., Chan, R. N. C., Chan, K. C. C., et al. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.10.008 · Cited by 16
Sorota, S. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000064 · Cited by 20
“It has been known for over 30 years that acute epinephrine infusion can induce insulin resistance in man.(80) There are a number of potential points of interaction between insulin and glucose metabolism with the sympathetic nervous system, although the relative importance of each hypothetical effect in vivo remains to…”
BackgroundDiabetes mellitus and the exocrine pancreas.
Gorelick, F. S. (1983) · PubMed Central · Cited by 16
Reversal of Insulin Resistance in Type 1 Diabetes following Initiation of Insulin Treatment
Gray, R. S., Cowan, P., Duncan, L. J. P., & Clarke, B. F. (1986) · Diabetic Medicine · doi:10.1111/j.1464-5491.1986.tb00699.x · Cited by 18
Benthem, L., Kuipers, F., Steffens, A. B., & SCHEURINK, A. J. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07804.x · Cited by 17
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset
Fliser, D., Keller, C. K., Bahrmann, P., Franek, E., Schreckling, H.-J., Bergis, K., & Ritz, E. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715030-00011 · Cited by 16
Regulation of Carbohydrate Metabolism by Cyclic Nucleotides
Exton, J. H. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68393-0_1 · Cited by 17
Rana, J. S., Hardison, R. M., Pop‐Busui, R., Brooks, M. M., Jones, T. L. Z., Nesto, R. W., Bourassa, M. G., & on behalf of the BARI 2D Investigators (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2010.00067.x · Cited by 15
Impact of videogame playing on glucose metabolism in children with type 1 diabetes
Phan-Hug, F., Thurneysen, E., Theintz, G. E., Ruffieux, C., & Grouzmann, E. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00770.x · Cited by 16
“E has been shown to alter glycemia by a direct stimulation of glucagon secretion contributing to the development of hyperglycemias (9) and by impairing tissue sensitivity to insulin through a adrenergic receptor effect (10).”
BackgroundAlpha 2-adrenergic modulation of pancreatic glucagon secretion in rats
Saito, M. K., Saitoh, T., & Inoue, S. (1992) · Physiology & Behavior · doi:10.1016/0031-9384(92)90303-j · Cited by 14
Eriksson, J. W., Lönnroth, P., & Smith, U. (1992) · Biochemical Journal · doi:10.1042/bj2880625 · Cited by 15
Clark, M. G., Patten, G. S., Filsell, O. H., & Rattigan, S. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80664-4 · Cited by 21
Ratzmann, K. P., Besch, W., Witt, S., & Schulz, B. (1981) · Diabetologia · doi:10.1007/bf00252653 · Cited by 15
Practical aspects of achieving positive energy balance in low birth weight infants
Heird, W. C., Jensen, C. L., & Gomez, M. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81246-6 · Cited by 15
Hypoglycemic glucose counterregulation in patients with insulin-dependent diabetes mellitus.
Cryer, P. E. (1982) · PubMed · Cited by 18
Prolonged insulin resistance following insulin-induced hypoglycaemia
Clore, J. N., Brennan, J. R., Gebhart, S. S. P., Newsome, H. H., Nestler, J. E., & Blackard, W. G. (1987) · Diabetologia · doi:10.1007/bf00274793 · Cited by 18
L�nnroth, P., Wesslau, C., Stenstr�m, G., Tisell, L. E., & Smith, U. (1985) · Diabetologia · doi:10.1007/bf00703133 · Cited by 14
“This is not surprising, however, since the effect of catecholamines on glucose levels in vivo is probably due to several actions such as an a-mediated inhibition of insulin secretion [25], increased hepatic glucose production [26] and reduced peripheral insulin sensitivity and responsiveness [2, 3].”
BackgroundEstimation of sympathetic activity in essential hypertension
Mj, B., Lhoste, F., Zamboulis, C., Ind, P. W., Jenner, D. A., & Dollery, C. T. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.3 · Cited by 15
Lack of a direct alpha-adrenergic effect of epinephrine on glucose production in human subjects
Best, J. D., Ward, W. K., Pfeifer, M. A., & Halter, J. B. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.3.e271 · Cited by 17
Carbohydrate metabolism and uraemia ? Mechanisms for glycogenolysis and gluconeogenesis
H�rl, W. H., Stępiński, J., & Heidland, A. (1980) · Journal of Molecular Medicine · doi:10.1007/bf01476876 · Cited by 15
Adiponectin and Adiponectin Receptors in Human Pheochromocytoma
Isobe, K., Fu, L., Tatsuno, I., Takahashi, H., Nissato, S., Hara, H., YASHIRO, T., Suzukawa, K., Takekoshi, K., Shimano, H., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no885 · Cited by 14
Shibasaki, S., Eguchi, K., Matsui, Y., Ishikawa, J., Hoshide, S., Ishikawa, S., Kabutoya, T., Pickering, T. G., Shimada, K., & Kario, K. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832a6d6a · Cited by 14
High Heart Rate as Predictor of Essential Hypertension:
Tjugen, T. B., Flaa, A., & Kjeldsen, S. E. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.05.008 · Cited by 18
Muscle Sympathetic Nerve Activity in Patients with Acromegaly
Capaldo, B., Lembo, G., Rendina, V., Guida, R., Marzullo, P., Colao, A. A. L., Lombardi, G., & Saccà, L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6802 · Cited by 18
“Previous studies have shown that epinephrine infusion (9, 22) as well as endogenous sympathetic overactivity (10) are able to reduce insulin-stimulated glucose disposal in forearm tissues, predominantly by b -adrenergic mechanisms.”
6 Hypoglycaemic Agents Which Do Not Release Insulin
Steiner, K., & Lien, E. L. (1987) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70423-5 · Cited by 17
Factors regulating the disposal of an oral glucose load in normal, diabetic, and obese subjects
Waldhäusl, W. K., & Bratusch-Marrain, P. R. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030105 · Cited by 14
Smith, H., Hengist, A., Thomas, J. E., Walhin, J., Heath, P., Perkin, O. J., Chen, Y., Gonzalez, J. T., & Betts, J. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001865 · Cited by 15
“Additionally, caffeine ingestion is a stimulant for the release of adrenaline, which suppresses the action of insulin through β -adrenergic receptor activation (28 – 30) .”
HYPERTENSION IN DIABETES MELLITUS
Arauz-Pacheco, C., & Raskin, P. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70330-3 · Cited by 16
Adrenergic blockade and hypoglycaemia
Lager, I. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb01615.x · Cited by 14
Carbohydrate metabolism in uremia
MAK, R. H. K. (1989) · Pediatric Nephrology · doi:10.1007/bf00852911 · Cited by 13
Type A behavior and metabolic syndrome precursors in young adults
Ravaja, N., Keltikangas‐Järvinen, L., & Viikari, J. S. A. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00524-2 · Cited by 15
Holck, P., Pørksen, N. K., Nielsen, M. F., Nyholm, B., Bak, J. F., Andreasen, F., Møller, N., & Schmitz, O. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.4.e544 · Cited by 14
Increased insulin sensitivity in the high sodium one-kidney, one figure-8 hypertensive rat.
Frontoni, S., Ohman, L., Haywood, J. R., & Rossetti, L. (1992) · Hypertension · doi:10.1161/01.hyp.20.2.192 · Cited by 13
Earl, L. R., Thompson, D. L., & Mitcham, P. B. (2011) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2011.06.008 · Cited by 13
“Administration of epinephrine alone, without exercise, reduces both whole body insulin sensitivity in humans [24] and isolated muscle sensitivity in rats [25].”
BackgroundResultExtrarenal Potassium Metabolism
Rosa, R. M., & Epstein, F. H. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50049-8 · Cited by 12
Dickson, J. L., Alsweiler, J. M., Gunn, C. A., Pretty, C. G., & Chase, J. G. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815596175 · Cited by 14
“Page 16 of 21 and adrenaline [39-41].”
Prunet, B., Basely, M., D’Aranda, E., Cambefort, P., Pons, F., Cimarelli, S., Dagain, A., Desse, N., Veyrières, J.-B., Jégo, C., et al. (2014) · Critical Care · doi:10.1186/cc13943 · Cited by 12
Oh, Y. T., Tran, D., Buchanan, T. A., Selsted, M. E., & Youn, J. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00131.2015 · Cited by 12
Changes in Muscle Glucose Metabolism in Type 1 Diabetes
Koivisto, V. A., & Yki‐Järvinen, H. (1990) · Annals of Medicine · doi:10.3109/07853899009147270 · Cited by 12
Acute Effects of Blood Pressure Elevation on Insulin Clearance in Normotensive Healthy Subjects
O'Callaghan, C. J., Komersova, K., & Louis, W. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.104 · Cited by 12
“In previous studies, b-adrenergic stimulation has not modified insulin concentrations during euglycemic hyperinsulinemia.(19,24) Outwardly, this implies that insulin clearance has not changed; however, under some conditions, b-adrenergic stimulation increases endogenous insulin secretion.”
BackgroundPloug, T., Han, X., Petersen, L. N., et al. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.1.e7 · Cited by 12
Walters, J. M., Ward, G. M., Kalfas, A., Best, J. D., & ALFORD, F. P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90062-f · Cited by 12
Jaber, L. A., Lewis, N. J., Slaughter, R. L., & Neale, A. V. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03950.x · Cited by 14
Weber, J., Tanawattanacharoen, V. K., Seagroves, A., Liang, M. C., Koppin, C. M., Ross, H. M., Bachega, T. A. S. S., Geffner, M. E., Serrano-Gonzalez, M., Bhullar, G., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab600 · Cited by 11
Cincotta, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713255 · Cited by 12
“d © [312,313,340,382–392], e © [305,393–398], f © [394,395]; g © [305,399,400]; h © [401–403]; i © [403,404];”
Modified method for the performance of glucose insulin clamp studies in conscious rats
Cheung, A. P., & Bryer‐Ash, M. (1994) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(94)90006-x · Cited by 11
Outcomes of Sleep Disordered Breathing in Pregnancy
Bourjeily, G. R., Mazer, J. M., & Paglia, M. J. (2013) · The Open Sleep Journal · doi:10.2174/1874620901306010028 · Cited by 11
Wu, S., Chen, W., Shen, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00467-3 · Cited by 11
Guðbjörnsdóttir, S., Fowelin, J., Elam, M., Attvall, S., Bengtsson, B. ‐., Mårin, P., & Lönnroth, P. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.670617.x · Cited by 11
Causes and consequences of sympathetic overactivity in hypertension
Shlyakhto, E. V., & Conrady, A. Ο. (2003) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2003-9-3-81-88 · Cited by 15
Do ACE inhibitors improve insulin sensitivity?
Petrie, J. R., Morris, A. D., Ueda, S., Elliott, H. L., Connell, J. C., SMALL, M. P., & Donnelly, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91425-0 · Cited by 11
Caffeine and Insulin Sensitivity
Acheson, K. J. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.19 · Cited by 13
“…is increased and free fatty acids and glycerol are released into the peripheral circulation In resting conditions, epinephrine impairs insulin action on both peripheral and hepatic tissue, 25,26 which may be exacerbated to some extent in individuals who are already glucose intolerant or diabetic.”
Role of counterregulatory hormones in the regulation of hepatic glucose metabolism
Saccà, L. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030110 · Cited by 12
Exercise and Protein Metabolism
Evans, W. J. (2015) · World review of nutrition and dietetics · doi:10.1159/000422347 · Cited by 10
Effect of counterregulatory hormones on kinetic response to ingested glucose in dogs
Saccà, L., Cicala, M., Corso, G., Ungaro, B., & Sherwin, R. S. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.5.e465 · Cited by 11
Adrenal-Medullary Activity and Cardiovascular Control in the Fetal Sheep
Jones, C. T., & Wei, G. (1985) · Springer eBooks · doi:10.1007/978-3-642-70358-4_14 · Cited by 11
Functional class in patients with heart failure is associated with the development of diabetes
Bell, D. S. H. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00392-9 · Cited by 10
Body mass, chronic heart failure, surgery and survival
Clark, A. L., & Anker, S. D. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.07.004 · Cited by 12
Roche, J., Corgosinho, F. C., Isacco, L., Scheuermaier, K. D., Pereira, B., Gillet, V., Moreira, G. A., Pradella-Hallinan, M. L. D. C., Tufik, S., de Mello, M. T., et al. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.06.030 · Cited by 11
Administration of tibolone decreases 24 h heart rate but not blood pressure of post-menopausal women
Cagnacci, A., Baldassari, F. V. M., Arangino, S., Alessandrini, C., & Volpe, A. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.08.011 · Cited by 11
“the hyperactivity of the adrenergic system [30,31].”
Association of sympathetic nervous system activity with polycystic ovarian syndrome
Li, W., Chen, Y., & Xu, L. (2014) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog16592014 · Cited by 11
Waldhäusl, W. K., Bratusch-Marrain, P. R., Komjati, M., Breitenecker, F., & TROCH, I. (1992) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.148386 · Cited by 9
Fuel utilization in marathons: Implications for performance
Hoyt, C. J. (1982) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198204000-00141 · Cited by 11
Høieggen, A. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01306-6 · Cited by 9
MAD2-Dependent Insulin Receptor Endocytosis Regulates Metabolic Homeostasis
Park, J., Hall, C., Hubbard, B. T., LaMoia, T. E., Gaspar, R. C., Nasiri, A. R., Li, F., Zhang, H., Kim, J., Haeusler, R. A., et al. (2023) · Diabetes · doi:10.2337/db23-0314 · Cited by 10
Heart or Mind? Unexplained Chest Pain in Patients with and Without Coronary Disease
Garroni, D., & Fragasso, G. (2018) · Heart and Mind · doi:10.4103/hm.hm_14_18 · Cited by 9
“[49] In addition to the effect of vasoconstriction, sympathetic stimulation can also induce acute insulin resistance through alpha-adrenergic receptors and blockade with propranolol can reinstate a normal glucose uptake.[50] Whatever the mechanism, insulin-resistant states,”
BackgroundImpact of Sleep and Circadian Disturbances on Glucose Metabolism and Type 2 Diabetes
Reutrakul, S., Punjabi, N. M., & Cauter, E. V. (2018) · Cited by 22
Ridder, F. D., Ledeganck, K. J., Winter, B. Y. D., Braspenning, R., Delbeke, D., Renard, É., Pozzilli, P., Pieralice, S., Vissers, D. K., & Block, C. E. M. D. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3537 · Cited by 12
“counterregulatory hormones; mainly growth hormone and catecholamines resulting in an increased hepatic glucose production and inhibition of insulin‐mediated glucose uptake by peripheral tissue.(30) Increased levels of cortisol can result in the acute inhibition of glucose utilisation in skeletal muscles resulting in h…”
BackgroundSvart, M. V., Rittig, N. F., Kampmann, U., Voss, T. S., Møller, N., & Jessen, N. (2017) · Diabetologia · doi:10.1007/s00125-017-4271-x · Cited by 9
Hasegawa, T., & Watase, H. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.259 · Cited by 9
Insulin Resistance and Blood Pressure
Ferrannini, E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_15 · Cited by 14
β-Adrenergic Blockade Increases the Hepatic Extraction of Glucose in Sepsis
Caruana, J. A. (1986) · Archives of Surgery · doi:10.1001/archsurg.1986.01400030073013 · Cited by 9
Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans
DAVIS, M. R., & Shamoon, H. (1992) · Metabolism · doi:10.1016/0026-0495(92)90156-5 · Cited by 8
Arner, P., Hellmér, J., Ewerth, S., & Östman, J. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90444-3 · Cited by 9
Subunit Structure and Regulation of the Insulin-Receptor Complex
Pessin, J. E., Mottola, C., Yu, K., et al. (1985) · Springer eBooks · doi:10.1007/978-1-4684-4874-0_1 · Cited by 9
Al-Sabri, M. H., Nikpour, M., Clemensson, L. E., Attwood, M. M., Williams, M. J., Rask-Anderson, M., Mwinyi, J., & Schiöth, H. B. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00891-7 · Cited by 9
Glycogen synthase activity in two rat models of hypertension
Farrace, S., Frontoni, S., Gambardella, S., et al. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00266-r · Cited by 8
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats
Muscogiuri, G., Kamat, A., Balas, B., Giaccari, A., DeFronzo, R. A., Musi, N., & Katz, M. S. (2011) · Endocrine Research · doi:10.3109/07435800.2010.539993 · Cited by 9
“Interestingly, in humans adrenergic responsive stimulation of HGP is mediated primarily through β-AR signaling (28,29), and β-AR expression has been demonstrated in human liver with a variety of methods (30–33).”
BackgroundSelf-citationCasagrande, S. S., Cowie, C. C., Sosenko, J. M., Mizokami‐Stout, K., Boulton, A. J. M., & Pop‐Busui, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa055 · Cited by 10
Role of PDK4 in insulin signaling pathway in periadrenal adipose tissue of pheochromocytoma patients
Wu, C., Zhang, H., Lin, X., Zeng, Y., Zhang, Y., Ma, X., Xue, Y., & Guan, M. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0293 · Cited by 8
Matsuda, Y., Sakurai, T., Iino, M., et al. (1994) · Journal of Anesthesia · doi:10.1007/bf02514660 · Cited by 8
“At the same time, hyperglycemia is prevented, and there is no impairment of insulin secretion [16,18], Similarly, impaired insulin secretion during surgical stress is reversed by the alpha adrenergic antagonist phentolamine [19].”
BackgroundMohamed, R. M. S. M., Morimoto, S., Ibrahim, I. A. A. E.-H., Zhan, D., Du, C., Arioka, M., Yoshihara, T., Takahashi‐Yanaga, F., & Sasaguri, T. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00771.2015 · Cited by 10
“inositol 3-kinase/Akt signaling pathway (6, 8, 20).”
Kahn, S. E. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.02.005 · Cited by 9
Influence of subconjunctival steroid injection on blood glucose profile in diabetic rats
Fukushima, H., Kato, S., Hayashi, Y., et al. (2001) · Eye · doi:10.1038/eye.2001.104 · Cited by 8
Cryer, P. E. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50025-6 · Cited by 8
Counterregulatory hormone responses during graded hyperinsulinermic euglycemia in conscious rats
Koopmans, S. J., de Boer, S. F., Radder, J. K., Frölich, M., & Krans, H. M. J. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90338-g · Cited by 11
“The suppressive effect of insulin on plasma glucagon, irrespective of ambient glucose levels, has been described (8,24,37), although a recent study (4) could not detect any effect of chronic hyperinsulinemia on plasma glucagon levels in rats.”
BackgroundPreoperative feeding does not reverse postoperative insulin resistance in skeletal muscle in the rat
Strömmer, L., Isaksson, B., Arnelo, U., Lundkvist, I., Östenson, C., Wickbom, M., Herrington, M. K., & Permert, J. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80013-x · Cited by 8
Management of Hypertension in Diabetes
Arauz-Pacheco, C., & Raskin, P. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30222-6 · Cited by 8
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.